Cell type-specific gene regulatory atlas prioritizes drug targets and repurposable medicines in Alzheimer's disease.

Alzheimer's disease (AD) is a complex and poorly understood neurodegenerative disorder that lacks sufficiently effective treatments. Computational and integrative analyses that leverage multiomics data provide a promising strategy to uncover disease…

Preview only. Read the full abstract at the source